APPLICATIONS PUBLISHED 3 JULY 2002
Published: 1-Jan-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Using quaternary ammonium salts for transdermal drug delivery
Watson Pharmaceuticals 1217975*
Apparatus for electrically preparing injectable substances
Orlon, Kevin 1217981*
Compsns comprising insoluble and deformable flat organic particles
L'Oreal 1217982*
Proteinic drug delivery system using membrane mimetics
Generex Pharmaceuticals 1217988*
Liposome-entrapped DNA oral vaccines
Lipoxen 1217989*
Cationic dosper virosomes
Nika Health Products 1217990*
Emulsion-based processes for making microparticles
Southern Biosystems 1217991*
Coated solid dosage forms
American Home Products 1217992*
Bioadhesive nanoparticulate compsns having cationic surface stabilisers
Elan Pharma 1217993*
Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
Bayer 1217994*
Anti-mycobacterium compsns and methods of preparing and using same
Advanced Life Sciences 1217995*
Use of xanthophylls, astaxanthin eg for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections
Astacarotene 1217996*
A process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long-acting antihistamine
Ranbaxy Laboratories 1217997*
Use of (+)-tramadol, O-demethyltramadol or (+)-O-demethyltramadol, O-desmethyl-N-mono-desmethyl-tramadol or (+)-O-desmethyl-N-mono-desmethyl-tramadol for treating urinary incontinence
Gruenenthal 1217998*
Use of baclofen in the treatment of alcoholism
Neuroscienze 1217999*
Anti-cancer nitro- and thio-fatty acids
Women's and Children's Hospital 1218000*
Ultrafine L-carnitine, methods of preparing same, compsns containing same, and methods of using the same
Sigma-Tau Healthscience 1218001*
Use of flavone 8-acetic acid in vascular and cardiovascular interventions and acute coronary syndromes
Mruk, Jozef 1218002*
Compsn and method for decreasing neurological symptomatology
Swope, David 1218003*
Use of cell membrane penetrating indigoid bisindole derivatives
Fiebig, Heinz Herbert 1218004*
Vitronectin receptor antagonists
SmithKline Beecham 1218005*
Indol-3-glyoxylic acid derivatives comprising therapeutically valuable proteins
Baxter Healthcare 1218006*
Optically active isomers of ketotifen and therapeutically active metabolites thereof
Bridge Pharma 1218007*
New use of 1,2,4-triazolo[1,5-A]pyrimidines
Knoll 1218008*
Quetiapine granules
AstraZeneca 1218009*
1,4-benzothaizepines to treat obesity-related disorders
Knoll 1218010*
Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, DNA viruses and retroviruses
Bernstein, Lawrence R 1218011*
Use of alprostadil (prostaglandin E1) for producing a medicament for angioneogenesis
Mehrabi, Mohammed Reza 1218012*
Phospholipid prodrugs of anti-proliferative drugs
D-Pharm Limited 1218013*
Compsns comprising progestrone analogues for the treatment of inflammatory conditions
University of Pennsylvania 1218014*
Pharmaceutical compsn of nateglinide and other antidiabetic agent
Novartis 1218015*
Combination of a statin and ex-vivo treated blood for treating atherosclerosis
Vasogen Ireland 1218017*
Use of colostrinin, constituent peptides thereof, and analogues thereof as oxidative stress regulators
The University of Texas System 1218018*
Oncolytic virus
Pro-Virus 1218019*
Treatment of diabetic nephropathy and microabuminuria
Shiva Biomedical 1218020*
Apple tree branch extracts for dermatological and cosmetic use and method for preparing the same
Pierre Fabre Dermo-Cosmetique 1218021*
Compsn for the prevention and/or treatment of circulatory disorders, comprising derivatives of L-carnitine and extracts of gingko biloba
Sigma-Tau Healthscience 1218022*
Method of calming human beings using personal care compsns
Johnson & Johnson 1218023*
Viscosity modulating substance and use thereof
Oklahoma Medical Research Foundation 1218024*
Use of mullerian inhibiting substance for treating excess androgen states
The General Hospital Corp 1218025*
Method to enhance healing of sternum after sternotomy
Kagen Pharmaceutical; Komeda, Masashi; Tabata, Yasushiko 1218026*
Compsn for stabilising corneal tissue during or after orthokeratological lens wear
Dewoolfson, Bruce Howard; Devore, Dale 1218027*
Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigenspecific T cell responses
Leids Universitair Medisch Centrum 1218028*
Use of an outer membrane protein A of an enterobacterium associated with a RSV immunogenic peptide for preparing vaccines for intranasal administration
Pierre Fabre Medicament 1218029*
Methods and compsns for the treatment and prevention of graft rejection using heat shock proteins
Fordham University 1219030*
Pharmaceutical compsn containing an antigen
Cistem Biotechnologies 1218031*
Treatment of refractory human tumours with epidermal growth factor receptor antagonists
Imclone Systems 1218032*
Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest
Universite Paris-Nord 1218033*
Binding agents
Isis Innovation 1218034*
Rapid peg-modification of viral vectors
The Trustees of the University of Philadelphia 1218035*
Topical scar treatment using a mixture of silicones
Smith & Nephew 1218038*
High citrate dialysate and uses thereof
Advanced Renal Technologies 1218039*
Anti-inflammatory nitro- and thio-fatty acids
Women's and Children's Hospital 1218333*
Preparation of amino-protected lysine derivatives
Abbott Laboratories 1218338*
Sulphonyl carboxamide derivatives. method for their production and their use as medicaments
Aventis Pharma Deutschland 1218341*
Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof
Sugen 1218342*
Pyrimidine carboxamide derivatives and combinatorial libraries thereof
LION Bioscience 1218343*
Pyrazole derivatives
F Hoffmann-La Roche 1218346*
Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compsns
Signal Pharmaceutical 1218347*
Indazole compounds and pharmaceutical compsns for inhibiting protein kinases, and methods for their use
Agouron Pharmaceuticals 1218348*
Method for selectively dissociating cyclic carboxylic acid anhydrides
Merck 1218349*
Nitroimidazole derivative and diagnostic imaging agent containing the same
Pola Chemical Industries; Takai, Yoshihiro; Ido, Tatsuo 1218351*
Benzimidazole derivatives having mixed seratonine and dopamine receptors affinity
Boehringer Ingelheim 1218352*
Quinazoline derivatives
AstraZeneca 1218353*
Quinazoline derivatives and their use as pharmaceuticals
AstraZeneca 1218354*
Therapeutic quinazoline derivatives
AstraZeneca 1218355*
Quinazoline compounds and pharmaceutical compsns containing them
AstraZeneca 1218356*
Quinazoline derivatives
AstraZeneca 1218357*
Therapeutic quinazoline compounds
AstraZeneca 1218358*
Piperazine compounds
Glaxo Group 1218359*
Triazine kinase inhibitors
Amgen 1218360*
Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents
Bristol-Myers Squibb 1218361*
Compsn and methods for modulating apoptosis in cells over-expressing BCL-2 family member proteins
Fred Hutchison Cancer Research Centre 1218368*
Quinolyl propyl piperadine derivatives and their use as antibacterial agents
Aventis Pharma 1218370*
Disubstituted iminoheterocyclic compounds
Suntory 1218371*
Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
Boehringer Ingelheim Pharmaceuticals 1218372*
Pharmaceutically active sulfonamide derivatives
Applied Research Systems 1218374*
Tyrosine kinase inhibitors
Merck 1218376*
Amino lactam sulphonamides as inhibitors of b-lactam production
Bristol-Myers Squibb Pharma 1218377*
Tetracyclic benzimidazole derivatives and combinatorial libraries thereof
LION Bioscience 1218384*
